Clinical Trials Browser

Phase NA × Breast Neoplasms × Genetic Testing × Clear all

Brain Neoplasms, Breast Neoplasms, Neoplasms, Unknown Primary

NCT04354675 2026-03-31

Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer

Phase NA Completed

35 enrolled

Breast

Breast Neoplasms

NCT05694559 2026-02-19

Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics

Phase NA Recruiting

1,000 enrolled

BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms

NCT02620852 2025-11-25

WISDOM

Phase NA Recruiting

100,000 enrolled

Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT03731845 2025-11-20

ESIGON

Phase NA Active not recruiting

73 enrolled

BreastGynecologic

Breast Neoplasms, Primary Ovarian Insufficiency

NCT05649072 2025-11-19

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

Phase NA Recruiting

1,000 enrolled

BreastGastrointestinalGynecologic

Breast Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT03246841 2024-12-12

TUMOSPEC

Phase NA Active not recruiting

7,274 enrolled

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

NCT02664389 2020-06-30

PANEL

Phase NA Completed

289 enrolled

BreastGastrointestinalGynecologic

Breast Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT01460186 2019-01-15

StoRM

Phase NA Completed

1,000 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

Clinical Trials

Cancer Genetic Testing in Ethnic Populations

Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer

Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics

WISDOM

ESIGON

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

TUMOSPEC

PANEL

StoRM